ZW6889A1 - &-adrenergic receptor antagonists - Google Patents

&-adrenergic receptor antagonists

Info

Publication number
ZW6889A1
ZW6889A1 ZW68/89A ZW6889A ZW6889A1 ZW 6889 A1 ZW6889 A1 ZW 6889A1 ZW 68/89 A ZW68/89 A ZW 68/89A ZW 6889 A ZW6889 A ZW 6889A ZW 6889 A1 ZW6889 A1 ZW 6889A1
Authority
ZW
Zimbabwe
Prior art keywords
receptor antagonists
adrenergic receptor
antagonists
adrenoceptor
alpha
Prior art date
Application number
ZW68/89A
Other languages
English (en)
Inventor
Joseph Lafferty John
Michael Demarinis Robert
Walter Venslavsky Joseph
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZW6889A1 publication Critical patent/ZW6889A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
ZW68/89A 1988-06-01 1989-05-29 &-adrenergic receptor antagonists ZW6889A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20081688A 1988-06-01 1988-06-01

Publications (1)

Publication Number Publication Date
ZW6889A1 true ZW6889A1 (en) 1989-08-30

Family

ID=22743334

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW68/89A ZW6889A1 (en) 1988-06-01 1989-05-29 &-adrenergic receptor antagonists

Country Status (13)

Country Link
EP (1) EP0344982B1 (de)
JP (1) JPH03504606A (de)
KR (1) KR900701788A (de)
CN (1) CN1038099A (de)
AT (1) ATE114310T1 (de)
AU (1) AU630100B2 (de)
CA (1) CA1320485C (de)
DE (1) DE68919438T2 (de)
NZ (1) NZ229296A (de)
PT (1) PT90717B (de)
WO (1) WO1989012051A1 (de)
ZA (1) ZA894096B (de)
ZW (1) ZW6889A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0344980A3 (de) * 1988-06-01 1991-05-15 Smithkline Beecham Corporation Alpha-adrenergische Rezeptorantagonisten
CN100391460C (zh) * 2002-06-20 2008-06-04 诺瓦乐医药公司 α-肾上腺素能受体拮抗剂的稳定配方及其用途
EP2824106B1 (de) 2012-03-06 2016-11-23 Takeda Pharmaceutical Company Limited Tricyclische verbindung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795451A (fr) * 1972-02-23 1973-08-16 Pfizer Agents hypoglycemiants aza indoliques tricycliques
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
EP0139584B1 (de) * 1983-10-17 1988-05-18 Synthelabo Imidazolinderivate, ihre Herstellung und therapeutische Verwendung
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
EP0344980A3 (de) * 1988-06-01 1991-05-15 Smithkline Beecham Corporation Alpha-adrenergische Rezeptorantagonisten

Also Published As

Publication number Publication date
DE68919438D1 (de) 1995-01-05
AU3770889A (en) 1990-01-05
WO1989012051A1 (en) 1989-12-14
EP0344982B1 (de) 1994-11-23
EP0344982A2 (de) 1989-12-06
ZA894096B (en) 1990-06-27
DE68919438T2 (de) 1995-05-04
CN1038099A (zh) 1989-12-20
NZ229296A (en) 1991-05-28
PT90717B (pt) 1994-11-30
JPH03504606A (ja) 1991-10-09
CA1320485C (en) 1993-07-20
EP0344982A3 (de) 1991-05-15
KR900701788A (ko) 1990-12-04
PT90717A (pt) 1989-12-29
ATE114310T1 (de) 1994-12-15
AU630100B2 (en) 1992-10-22

Similar Documents

Publication Publication Date Title
DE69034103D1 (de) Imidazoalkensäure
PL287631A1 (en) Method of obtaining novel substituted derivatives of n-/imidazolil/-alkyl-alamine
ZW6789A1 (en) &-adrenergic receptor antagonists
ZA894096B (en) Alpha-adrenergic receptor antagonists
EP0344980A3 (de) Alpha-adrenergische Rezeptorantagonisten
ZW6989A1 (en) &-adrenergic receptor antagonists
GR3007498T3 (de)
AU3601989A (en) Improvements in or relating to serotonin antagonists